Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

157
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
157
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

117
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
117
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

137
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
137
Pneumothorax-II01:27

Pneumothorax-II

110
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
110
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

1.7K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

271
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
271

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anatomical risk factors for descending necrotizing mediastinitis in deep neck infections.

Turk gogus kalp damar cerrahisi dergisi·2026
Same author

Daughter vesicles in primary diaphragmatic hydatid cyst.

Thorax·2026
Same author

Unusual primary hydatid cysts of the body without liver and lung involvement.

Journal of parasitic diseases : official organ of the Indian Society for Parasitology·2026
Same author

Diffuse Pericardial and Diaphragmatic Involvement of Alveolar Echinococcosis in a Liver-Transplanted Patient.

Revista da Sociedade Brasileira de Medicina Tropical·2026
Same author

Pulmonary malignant tumor metastasis or alveolar echinococcosis metastasis: the radiological dilemma.

Indian journal of thoracic and cardiovascular surgery·2025
Same author

Ruptured Pulmonary Hydatid Cyst.

The New England journal of medicine·2025

Related Experiment Video

Updated: May 17, 2025

Transient Transduction of the Strobilated Forms of Echinococcus granulosus
13:25

Transient Transduction of the Strobilated Forms of Echinococcus granulosus

Published on: September 16, 2022

2.9K

Current Management of Pulmonary Hydatid Cyst.

Yener Aydın1, Ulaş Ali Bilal1, Ayşenur Dostbil2

  • 1Department of Thoracic Surgery, Atatürk University Faculty of Medicine, Erzurum, Türkiye.

The Eurasian Journal of Medicine
|May 16, 2025
PubMed
Summary

Pulmonary hydatid disease, caused by Echinococcus granulosus, affects the lungs secondarily. Surgery is the primary treatment for lung hydatid cysts, with medical therapy used adjunctively.

More Related Videos

Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst
03:10

Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst

Published on: March 31, 2023

7.5K
Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus
08:59

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Published on: March 28, 2025

105

Related Experiment Videos

Last Updated: May 17, 2025

Transient Transduction of the Strobilated Forms of Echinococcus granulosus
13:25

Transient Transduction of the Strobilated Forms of Echinococcus granulosus

Published on: September 16, 2022

2.9K
Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst
03:10

Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst

Published on: March 31, 2023

7.5K
Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus
08:59

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Published on: March 28, 2025

105

Area of Science:

  • Medical Parasitology
  • Thoracic Surgery
  • Infectious Diseases

Background:

  • Hydatid disease is a zoonotic infection caused by Echinococcus granulosus.
  • Pulmonary involvement is the second most common site affected by hydatid cysts in both children and adults.
  • Cyst growth is more rapid in children, and the disease is more prevalent in this age group.

Purpose of the Study:

  • To review the diagnosis and management of pulmonary hydatid cysts.
  • To highlight surgical considerations and medical treatment protocols.

Main Methods:

  • Review of clinical and radiological diagnostic methods for hydatid cysts.
  • Discussion of surgical techniques for pulmonary hydatid cyst removal.
  • Analysis of the role of albendazole in treatment and prevention of recurrence.

Main Results:

  • Uncomplicated hydatid cysts are clinically and radiologically straightforward to diagnose.
  • Complicated cysts present diagnostic challenges.
  • Surgical treatment is promptly planned, with cystotomy and capitonnage being the preferred method to preserve lung parenchyma.

Conclusions:

  • Surgical intervention is the definitive treatment for pulmonary hydatid cysts.
  • Albendazole is indicated for preventing recurrence post-surgery or when surgery is not feasible.
  • Preoperative albendazole is contraindicated for intact cysts due to rupture risk.